Timothy Hoey Net Worth & Insider Trades

Timothy Hoey - SVP, Oncomed Pharmaceuticals Inc

As of April 25, 2017

What is Timothy Hoey's Net Worth?

The current estimated net worth of Oncomed Pharmaceuticals Inc's SVP, Timothy Hoey, is estimated to be about $2.39M . Timothy Hoey owns about 57,225 units of Oncomed Pharmaceuticals Inc common stock. In the last 4 years at Oncomed Pharmaceuticals Inc, Timothy Hoey has sold an estimated value of $1.05M worth.

What is Timothy Hoey's Past Insider Trading?

Timothy Hoey's largest purchase order was 12,763 units , worth over $18.25K on January 5, 2017. Timothy Hoey's largest sale order was 6,887 units , worth over $176.64K on April 29, 2015. In total, Timothy Hoey has made about 18 transactions over 4 years of their time at Oncomed Pharmaceuticals Inc. Timothy Hoey usually trades in April, with the busiest year in 2014. The most recent transaction was a sale order of 5,754 units , worth over $52.11K on April 5, 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Timothy Hoey's' Mailing Address?

  • Mailing address is C/o Tenaya Therapeutics, Inc. 171 Oyster Point Boulevard, 5th Flr. South San Francisco CA 94080 CA

Oncomed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Total
John A. Lewicki, Ph.D., 2017 $419,777 $192,925 $967,675 $167,911 $1,748,288
John A. Lewicki, Ph.D., 2016 $407,550 $141,750 - $146,718 $696,018
Paul Hastings, 2017 $551,127 $169,650 $1,857,110 $60,624 $2,638,511
Paul Hastings, 2016 $535,075 $158,760 - $264,862 $958,697
Sunil Patel, 2017 $406,117 $183,600 $939,700 $167,780 $1,697,197
Austin Gurney, Ph.D., 2017 $365,612 $154,536 $804,964 $116,996 $1,442,108
Alicia Hager, J.D., Ph.D., 2017 $347,619 $154,536 $804,964 $125,143 $1,432,262
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1302573/000156459018009577/omed-def14a_20180622.htm

What are Oncomed Pharmaceuticals Inc's Past Insider Trades?

Oncomed Pharmaceuticals Inc's most recent insider trade came on December 26, 2018 by Austin Gurney who sold 11,117 units worth $6.67K . In the last 5 years, insiders at Oncomed Pharmaceuticals Inc have sold an estimated value of $14.76M and bought an estimated value of $23.88M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Austin Gurney, See Remarks,  John A Lewicki, President and CEO,  and Alicia J Hager, SVP and General Counsel .

OncoMed Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1